Peptidoglycan from Akkermansia muciniphila MucT: chemical structure and immunostimulatory properties of muropeptides.


Journal

Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124

Informations de publication

Date de publication:
13 07 2022
Historique:
received: 18 01 2022
revised: 05 03 2022
accepted: 04 04 2022
pubmed: 23 4 2022
medline: 16 7 2022
entrez: 22 4 2022
Statut: ppublish

Résumé

Akkermansia muciniphila is an intestinal symbiont known to improve the gut barrier function in mice and humans. Various cell envelope components have been identified to play a critical role in the immune signaling of A. muciniphila, but the chemical composition and role of peptidoglycan (PG) remained elusive. Here, we isolated PG fragments from A. muciniphila MucT (ATCC BAA-835), analyzed their composition and evaluated their immune signaling capacity. Structurally, the PG of A. muciniphila was found to be noteworthy due of the presence of some nonacetylated glucosamine residues, which presumably stems from deacetylation of N-acetylglucosamine. Some of the N-acetylmuramic acid (MurNAc) subunits were O-acetylated. The immunological assays revealed that muropeptides released from the A. muciniphila PG could both activate the intracellular NOD1 and NOD2 receptors to a comparable extent as muropeptides from Escherichia coli BW25113. These data challenge the hypothesis that non-N-acetylattion of PG can be used as a NOD-1 evasion mechanism. Our results provide new insights into the diversity of cell envelope structures of key gut microbiota members and their role in steering host-microbiome interactions.

Identifiants

pubmed: 35452117
pii: 6572163
doi: 10.1093/glycob/cwac027
doi:

Substances chimiques

Peptidoglycan 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

712-719

Subventions

Organisme : BBSRC
ID : BB/R017409/1

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Pilar Garcia-Vello (P)

Department of Chemical Sciences, University of Naples Federico II, Napoli 80126, Italy.

Hanne L P Tytgat (HLP)

Laboratory of Microbiology, Wageningen University, Wageningen 6708 WE, The Netherlands.

Joe Gray (J)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK.

Janneke Elzinga (J)

Laboratory of Microbiology, Wageningen University, Wageningen 6708 WE, The Netherlands.

Flaviana Di Lorenzo (F)

Department of Agricultural Sciences, University of Naples Federico II, Portici 80055, Italy.

Jacob Biboy (J)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK.

Daniela Vollmer (D)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK.

Cristina De Castro (C)

Department of Agricultural Sciences, University of Naples Federico II, Portici 80055, Italy.

Waldemar Vollmer (W)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK.

Willem M de Vos (WM)

Laboratory of Microbiology, Wageningen University, Wageningen 6708 WE, The Netherlands.
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.

Antonio Molinaro (A)

Department of Chemical Sciences, University of Naples Federico II, Napoli 80126, Italy.
Department of Chemistry, School of Science, Osaka University, 560-0043, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH